Skip to main navigation Skip to search Skip to main content

CREB-binding protein/p300 activates MyoD by acetylation

  • Anna Polesskaya
  • , Arnaud Duquet
  • , Irina Naguibneva
  • , Christoph Weise
  • , Arlette Vervisch
  • , Eyal Bengal
  • , Ferdinand Hucho
  • , Philippe Robin
  • , Annick Harel-Bellan
  • CNRS UPR 9079 Oncogénèse, Différenciation et Transduction du Signal
  • Laboratoire Oncogenèse
  • Institut für Chemie und Biochemie
  • Free University of Berlin
  • Service de Cytofluorométrie
  • Institut André Lwoff
  • The Rappaport Faculty of Medicine and Research Institute
  • Technion - Israel Institute of Technology

Research output: Contribution to journal › Article › peer-review

113 Citations (Scopus)

Abstract

The myogenic protein MyoD requires two nuclear histone acetyltransferases, CREB-binding protein (CBP)/p300 and PCAF, to transactivate muscle promoters. MyoD is acetylated by PCAF in vitro, which seems to increase its affinity for DNA. We here show that MyoD is constitutively acetylated in muscle cells. In vitro, MyoD is acetylated both by CBP/p300 and by PCAF on two lysines located at the boundary of the DNA binding domain. MyoD acetylation by CBP/p300 (as well as by PCAF) increases its activity on a muscle-specific promoter, as assessed by microinjection experiments. MyoD mutants that cannot be acetylated in vitro are not activated in the functional assay. Our results provide direct evidence that MyoD acetylation functionally activates the protein and show that both PCAF and CBP/p300 are candidate enzymes for MyoD acetylation in vivo.

Original languageEnglish
Pages (from-to)34359-34364
Number of pages6
JournalJournal of Biological Chemistry
Volume275
Issue number44
DOIs
Publication statusPublished - 3 Nov 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'CREB-binding protein/p300 activates MyoD by acetylation'. Together they form a unique fingerprint.

Cite this